Cornwall holiday lettings 'upstart' aims for £10m turnover

'We saw the niche and we grasped it'

RxSight, Inc. (RXST)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

60.65

-1.61

(-2.59%)

At close: 04:00PM EDT

60.18

-0.47

(-0.77%)

After hours:

05:02PM EDT

Loading interactive chart…

GlobeNewswire
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 shares of its common stock, at a price to the public of $56.00 per share, which includes the full exercise by the underwriters of their option to purchase up to 267,857 additional shares. RxSight’s gross
Simply Wall St.
RxSight, Inc. (NASDAQ:RXST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$72.75
A week ago, RxSight, Inc. ( NASDAQ:RXST ) came out with a strong set of quarterly numbers that could potentially lead...
Simply Wall St.
RxSight First Quarter 2024 Earnings: Beats Expectations
RxSight ( NASDAQ:RXST ) First Quarter 2024 Results Key Financial Results Revenue: US$29.5m (up 69% from 1Q 2023). Net...